BAC
Bank of America Corporation
BAC has the edge over L overall, supported by stronger modeled upside and stronger valuation.
L
Loews Corporation
L trails on the overall score without a compensating advantage in the available component scores.
BAC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
BAC's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like BAC.
L Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| N/A | |
| N/A |
L's profitability is currently healthy, and its revenue is stable. Free cash flow and net leverage aren't meaningful measures for financial services companies like L.
BAC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.4x | $39.50 | -22% |
| Forward | 10x | $50.51 | — |
| Current | 12x | $50.51 | — |
| Fair | 13x | $53.81 | +6.5% |
| Expensive | 15x | $62.23 | +23% |
Historical ranges are pointers, not guarantees.
BAC has the edge over L in the historical PE scenario, which offers more potential upside but is not a forecast.
L PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 11x | $75.96 | -32% |
| Fair | 13x | $92.78 | -17% |
| Expensive | 15x | $107 | -4.1% |
| Current | 15x | $112 | — |
Historical ranges are pointers, not guarantees.
L's PE is in its expensive range at 15x.
BAC Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for BAC, with profitability improving.
L Forward outlook
There aren't enough analyst estimates for L to show an outlook.
BAC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.92 | +17% |
| Q3 2026 | $4.19 | +14% |
| Q2 2026 | $4.34 | +27% |
| Q1 2026 | $4.02 | +20% |
| Q4 2025 | $3.81 | +19% |
| Q3 2025 | $3.66 | +33% |
| Q2 2025 | $3.41 | +20% |
| Q1 2025 | $3.35 | +16% |
| Q4 2024 | $3.21 | +4.2% |
BAC has the edge over L on earnings, with more consistent year-over-year improvement.
L Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $7.22 | +4.5% |
| Q2 2026 | $8.15 | +29% |
| Q1 2026 | $7.86 | +29% |
| Q4 2025 | $7.97 | +24% |
| Q3 2025 | $6.91 | -8.1% |
| Q2 2025 | $6.30 | -7.6% |
| Q1 2025 | $6.10 | -9.4% |
| Q4 2024 | $6.41 | +1.9% |
L earned $7.22 per share over the past year, up 4.5% from the year before.
BAC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $30B | +6.7% |
| Q2 2026 | $31.6B | +19% |
| Q1 2026 | $30.3B | +11% |
| Q4 2025 | $31.2B | +23% |
| Q3 2025 | $28.1B | +11% |
| Q2 2025 | $26.5B | +4.3% |
| Q1 2025 | $27.4B | +6% |
| Q4 2024 | $25.3B | +15% |
BAC has the edge over L on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 30% | -3.7 points |
| Q2 2026 | 37% | +7.6 points |
| Q1 2026 | 34% | +4.7 points |
| Q4 2025 | 40% | +12 points |
| Q3 2025 | 34% | +4.8 points |
| Q2 2025 | 29% | -0.7 points |
| Q1 2025 | 30% | +1.5 points |
| Q4 2024 | 28% | +14 points |
BAC has the edge over L on profitability, with a higher operating margin.
L Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $4.8B | +1.9% |
| Q2 2026 | $4.7B | +3.9% |
| Q1 2026 | $4.6B | +1.4% |
| Q4 2025 | $4.7B | +4.1% |
| Q3 2025 | $4.7B | +4.6% |
| Q2 2025 | $4.6B | +6.7% |
| Q1 2025 | $4.5B | +6.2% |
| Q4 2024 | $4.5B | +6.8% |
L's revenue has grown year over year for 17 quarters in a row: $4.8B last quarter, up 1.9% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 8.5% | -6.2 points |
| Q2 2026 | 13% | +1.1 points |
| Q1 2026 | 10% | -1.3 points |
| Q4 2025 | 11% | +7.3 points |
| Q3 2025 | 15% | +2.4 points |
| Q2 2025 | 12% | -0.1 points |
| Q1 2025 | 11% | -3.4 points |
| Q4 2024 | 4.1% | -10 points |
L's operating margin was 8.5% last quarter, down 6.2 points from the same quarter a year ago.
BAC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$6.5B | -114% |
| Q2 2026 | $29B | +$38.2B |
| Q1 2026 | $41.8B | +$44B |
| Q4 2025 | -$22.9B | -189% |
| Q3 2025 | $46.9B | +$84.2B |
| Q2 2025 | -$9.1B | -150% |
| Q1 2025 | -$2.2B | +$13.4B |
| Q4 2024 | $25.9B | -21% |
BAC has the edge over L on cash flow, with more consistent year-over-year improvement.
L Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $691M | -9.6% |
| Q2 2026 | $708M | -19% |
| Q1 2026 | -$132M | -121% |
| Q4 2025 | $426M | -44% |
| Q3 2025 | $764M | -3.8% |
| Q2 2025 | $872M | +10% |
| Q1 2025 | $638M | +1536% |
| Q4 2024 | $767M | +202% |
L's free cash flow was $1.7B over the past year, down 44% from the year before. Free cash flow isn't a meaningful measure for financial services companies like L.
BAC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1% | -72M shares |
| 1 year | -5.3% | -405M shares |
| 3 years | -11% | -854M shares |
| 5 years | -15% | -1.3B shares |
| Available history | -24% | -2.2B shares |
BAC has the edge over L on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $6B |
| Q2 2026 | $6B |
| Q1 2026 | $7.2B |
| Q4 2025 | $6.3B |
| Q3 2025 | $5.3B |
| Q2 2025 | $5.3B |
| Q1 2025 | $4.5B |
| Q4 2024 | $3.5B |
BAC spent $25.6B buying back its own shares over the past year, up 37% from the year before.
L Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.5% | -1M shares |
| 1 year | -1.5% | -3.1M shares |
| 3 years | -9.5% | -21.4M shares |
| 5 years | -20% | -52.7M shares |
| Available history | -33% | -98.8M shares |
L has 205M diluted shares, down 1.5% from a year ago, with $434M in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $149M |
| Q2 2026 | $154M |
| Q1 2026 | $31M |
| Q4 2025 | $100M |
| Q3 2025 | $55M |
| Q2 2025 | $257M |
| Q1 2025 | $394M |
| Q4 2024 | $346M |
L spent $434M buying back its own shares over the past year, down 59% from the year before.
BAC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 6.4x | High |
| Q2 2026 | 6.7x | High |
| Q1 2026 | 7.1x | High |
| Q4 2025 | 7.7x | High |
| Q3 2025 | 8.3x | High |
| Q2 2025 | 8.8x | High |
| Q1 2025 | 8.6x | High |
| Q4 2024 | 9.0x | High |
BAC's net debt is about 6.4 years of its operating earnings (EBITDA), down from 8.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like BAC.
L Net Leverage
BAC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.1 | Neutral |
| Stochastic | 4.9 | Oversold |
BAC's weekly RSI is 37 (neutral) and its Stochastic is 5 (oversold).
L Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.5 | Neutral |
| Stochastic | 51.5 | Neutral |
L's weekly RSI is 54 (neutral) and its Stochastic is 51 (neutral).
BAC PE vs Financial Services Sector
| Metric | BAC | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 7.5% below |
| PE % | 40 | 63 | 23 pts below |
BAC has the edge over L on valuation relative to its sector.
L PE vs Financial Services Sector
| Metric | L | Sector median | Relative |
|---|---|---|---|
| PE | 15x | 13x | 19% above |
| PE % | 93 | 63 | 30 pts above |
L is trading at 15x earnings, a 19% premium to the Financial Services sector's median of 13x.
BAC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $52.1 | 3% below |
| 20 week MA | $57.8 | 13% below |
| 50 week MA | $54.7 | 7.7% below |
| 100 week MA | $50.5 | 0% below |
| 200 week MA | $42.5 | 19% above |
BAC has fallen below most of its moving averages, though it's still 19% above its 200-week average.
L Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $109.1 | 2.5% above |
| 20 week MA | $111.3 | 0.4% above |
| 50 week MA | $108.9 | 2.7% above |
| 100 week MA | $100.1 | 12% above |
| 200 week MA | $84.9 | 32% above |
L has the edge over BAC on trend strength, trading above more of its moving averages.
BAC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $35.4 | $30.0 | -15% |
| 2021 | $30.0 | $44.4 | +48% |
| 2022 | $44.4 | $32.5 | -27% |
| 2023 | $32.5 | $33.7 | +3.7% |
| 2024 | $33.7 | $44.3 | +32% |
| 2025 | $44.3 | $56.2 | +27% |
| 2026 YTD | $56.2 | $50.5 | -10% |
BAC has finished higher in four of the last six years. It's down 10% so far in 2026.
L Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $51.9 | $44.0 | -15% |
| 2021 | $44.0 | $57.0 | +30% |
| 2022 | $57.0 | $57.9 | +1.5% |
| 2023 | $57.9 | $69.6 | +20% |
| 2024 | $69.6 | $84.7 | +22% |
| 2025 | $84.7 | $106.4 | +26% |
| 2026 YTD | $106.4 | $111.8 | +5.1% |
L has the edge over BAC on returns for 2026, with the stronger performance.